End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.139 EGP | +2.52% | -1.47% | +25.03% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 52.03 | 50.56 | 204.2 | 128 | 122.8 | 596.7 |
Enterprise Value (EV) 1 | 82.09 | 83.77 | 228.7 | 145.2 | 113.7 | 536.6 |
P/E ratio | 44.1 x | 9.11 x | 46.4 x | 16.7 x | 21.4 x | 150 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 2.24 x | 1.7 x | 5.56 x | 2.72 x | 2.07 x | 6.56 x |
EV / Revenue | 3.54 x | 2.81 x | 6.23 x | 3.09 x | 1.92 x | 5.9 x |
EV / EBITDA | 17.7 x | 10.4 x | 27.4 x | 11.5 x | 5.72 x | 12.9 x |
EV / FCF | 227 x | -16.8 x | 153 x | 19.4 x | 5.1 x | -62.1 x |
FCF Yield | 0.44% | -5.95% | 0.65% | 5.17% | 19.6% | -1.61% |
Price to Book | 1.02 x | 0.9 x | 3.13 x | 1.75 x | 1.56 x | 3.69 x |
Nbr of stocks (in thousands) | 320,000 | 320,000 | 345,000 | 345,000 | 345,000 | 655,000 |
Reference price 2 | 0.1626 | 0.1580 | 0.5920 | 0.3710 | 0.3560 | 0.9110 |
Announcement Date | 3/18/19 | 8/16/20 | 3/3/21 | 3/3/22 | 3/3/24 | 3/3/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 23.22 | 29.76 | 36.73 | 47.01 | 59.24 | 91.02 |
EBITDA 1 | 4.641 | 8.023 | 8.354 | 12.67 | 19.85 | 41.69 |
EBIT 1 | 2.493 | 5.587 | 5.002 | 8.997 | 15.56 | 36.63 |
Operating Margin | 10.74% | 18.77% | 13.62% | 19.14% | 26.26% | 40.24% |
Earnings before Tax (EBT) 1 | 1.688 | 5.825 | 4.308 | 8.336 | 18.25 | 7.134 |
Net income 1 | 1.179 | 5.55 | 4.406 | 7.678 | 5.738 | 2.102 |
Net margin | 5.08% | 18.65% | 12% | 16.33% | 9.69% | 2.31% |
EPS 2 | 0.003684 | 0.0173 | 0.0128 | 0.0223 | 0.0166 | 0.006093 |
Free Cash Flow 1 | 0.3623 | -4.982 | 1.492 | 7.499 | 22.27 | -8.638 |
FCF margin | 1.56% | -16.74% | 4.06% | 15.95% | 37.6% | -9.49% |
FCF Conversion (EBITDA) | 7.81% | - | 17.86% | 59.17% | 112.18% | - |
FCF Conversion (Net income) | 30.73% | - | 33.86% | 97.67% | 388.16% | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/18/19 | 8/16/20 | 3/3/21 | 3/3/22 | 3/3/24 | 3/3/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 30.1 | 33.2 | 24.4 | 17.2 | - | - |
Net Cash position 1 | - | - | - | - | 9.16 | 60.1 |
Leverage (Debt/EBITDA) | 6.477 x | 4.139 x | 2.925 x | 1.357 x | - | - |
Free Cash Flow 1 | 0.36 | -4.98 | 1.49 | 7.5 | 22.3 | -8.64 |
ROE (net income / shareholders' equity) | 2.34% | 10.4% | 7.27% | 11.1% | 7.56% | 1.75% |
ROA (Net income/ Total Assets) | 1.49% | 3.21% | 2.88% | 5.24% | 8.51% | 14.7% |
Assets 1 | 79.09 | 173.1 | 153.2 | 146.6 | 67.46 | 14.29 |
Book Value Per Share 2 | 0.1600 | 0.1700 | 0.1900 | 0.2100 | 0.2300 | 0.2500 |
Cash Flow per Share 2 | 0.0100 | 0 | 0 | 0 | 0.0300 | 0.0500 |
Capex 1 | 0.08 | 0.11 | 0.23 | 0.47 | 1.18 | 0.25 |
Capex / Sales | 0.34% | 0.38% | 0.63% | 1% | 1.99% | 0.28% |
Announcement Date | 3/18/19 | 8/16/20 | 3/3/21 | 3/3/22 | 3/3/24 | 3/3/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+25.03% | 15.56M | |
+19.25% | 21.59B | |
+9.59% | 17.85B | |
-10.47% | 9.84B | |
+19.47% | 9.34B | |
-3.70% | 5.12B | |
+2.28% | 4.94B | |
-4.10% | 2.99B | |
+12.13% | 2.98B | |
-1.02% | 2.43B |
- Stock Market
- Equities
- MEPA Stock
- Financials Medical Packaging Company